DOI: 10.1055/s-00000034

Klinische Pädiatrie

References

Rubie H, Chisholm J, Defachelles AS. et al.
Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Societe Francaise des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study.

J Clin Oncol 2006;
24: 5259-5264

Download Bibliographical Data

Access:
Access: